Harry L. Leider

Insider Reports History

Location
Boston, MA
Signature
/s/ Harry L. Leider
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Harry L. Leider:

Stock Role Class Num Shares Value Price $ Report Date Ownership
GELESIS HOLDINGS, INC. Chief Medical Officer Common Stock 314K 06 May 2022 Direct
GELESIS HOLDINGS, INC. Chief Medical Officer Stock Option (Right to Buy) 270K 06 May 2022 Direct
Organicell Regenerative Medicine, Inc. Chief Executive Officer, Director Common Stock 0 $1.32 19 Dec 2023 Indirect

Insider Reports Filed by Harry L. Leider

Symbol Company Period Transactions Value $ Form Type Role Filing Time
OCEL Organicell Regenerative Medicine, Inc. 19 Dec 2023 1 -$6.9K 4 Chief Executive Officer, Director 20 Dec 2023, 16:05
OCEL Organicell Regenerative Medicine, Inc. 28 Jun 2023 2 $10.4K 4/A Chief Executive Officer, Director 21 Dec 2023, 16:01
OCEL Organicell Regenerative Medicine, Inc. 28 Jun 2023 2 $59.4K 4 Chief Executive Officer, Director 30 Jun 2023, 16:05
OCEL Organicell Regenerative Medicine, Inc. 06 Jun 2023 0 $0 3 CEO and Director, Director 09 Jun 2023, 16:35
GLSH GELESIS HOLDINGS, INC. 06 May 2022 4 $0 4 Chief Medical Officer 09 May 2022, 16:17
GLSH GELESIS HOLDINGS, INC. 13 Jan 2022 0 $0 3 Chief Medical Officer 24 Jan 2022, 15:40